LYZ-13336-25514
4 vaccinations
3 coded responses
51 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 902 / CA
- Registered
- 2021-08-15
- Relationship
- Self
- Race
- Other
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-08-14
Dose 1 — Pfizer-BioNTech
-
2021-08-15
Registered in v-safe
- 2021-08-15
- 2021-08-16
- 2021-08-17
- 2021-08-18
- 2021-08-19
- 2021-08-20
- 2021-08-21
- 2021-08-28
-
2021-09-04
Dose 2 — Pfizer-BioNTech
- 2021-09-04
- 2021-09-05
- 2021-09-06
- 2021-09-07
- 2021-09-08
-
2021-09-09
Survey response — days 1–6 daily, dose 2MedDRA: Asthenopia — Feeling: Fair · Headache, Fatigue or tirednessFree text: Heavy eyesMedDRA releases: 2024-11 · check-in free text available
-
2021-09-10
Survey response — days 1–6 daily, dose 2MedDRA: Asthenopia, Dry eye, Head discomfort — Feeling: GoodFree text: Dry eyes/heavy eyes and headMedDRA releases: 2024-11 · check-in free text available
- 2021-09-11
- 2021-09-18
- 2021-09-25
- 2021-10-02
- 2021-10-09
- 2021-10-16
- 2021-12-04
- 2022-03-05
-
2022-03-14
Dose 3 — Pfizer-BioNTech
- 2022-03-14
- 2022-03-15
-
2022-03-16
Survey response — days 1–6 daily, dose 3MedDRA: Headache — Feeling: GoodFree text: Head throbbing, not headacheMedDRA releases: 2024-11 · check-in free text available
- 2022-03-17
- 2022-03-19
- 2022-03-20
- 2022-03-21
- 2022-03-30
- 2022-04-04
- 2022-04-11
- 2022-04-18
- 2022-04-25
- 2022-06-13
- 2022-09-12
-
2022-09-14
Dose 4 — Pfizer-BioNTechCo-administered: Flu
- 2022-09-14
- 2022-09-16
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-28
- 2022-10-05
- 2022-10-12
- 2022-10-19
- 2022-10-26
- 2022-12-14
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-08-14 | Pfizer-BioNTech | No |
| 2 | 2021-09-04 | Pfizer-BioNTech | No |
| 3 | 2022-03-14 | Pfizer-BioNTech | No |
| 4 | 2022-09-14 | Pfizer-BioNTech | Flu |
Free text
Release 9 — days 1–6 daily, dose 2
Systemic reaction (other): Heavy eyes
Systemic reaction (other): Dry eyes/heavy eyes and head
Release 11 — days 1–6 daily, dose 3
Systemic reaction (other): Head throbbing, not headache
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Asthenopia | · | · | ✓ |
| SRO | Dry eye | · | · | ✓ |
| SRO | Head discomfort | · | · | ✓ |
| SRO | Headache | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release